A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2004
11/11/2004	WO2004082626A3 Aromatase inhibitor diagnosis and therapy
11/11/2004	WO2004075853A9 Halogenated triptolide derivatives as immunomodulators and anticancer agents
11/11/2004	WO2004075825A3 Dosage forms of amlodipine and processes for their preparation
11/11/2004	WO2004071452A3 Random and non-random alkylene oxide polymer alloy compositions
11/11/2004	WO2004066963A3 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
11/11/2004	WO2004066944A3 Products for treating and preventing chronic diseases: eliminating the autoimmune triggers that underly chronic disease
11/11/2004	WO2004066920A3 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
11/11/2004	WO2004064773A3 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
11/11/2004	WO2004064750A3 Improved constructs for expressing lysosomal polypeptides
11/11/2004	WO2004044227A3 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
11/11/2004	WO2004037168A3 Treatment of pancreatitis with amylin
11/11/2004	WO2004017917A3 Method for the prevention and/or treatment of atherosclerosis
11/11/2004	WO2004012681A3 Cancer vaccines containing epitopes of oncofetal antigen
11/11/2004	US20040225179 Automated insomnia treatment system
11/11/2004	US20040225139 a 3-oxo-androstrane carbothioic acid compound
11/11/2004	US20040225005 substituted with p-chlorobenzene and a pyrrolethoxybenzene; antitumor
11/11/2004	US20040225004 Administering diindolylymethane (DIM and related indole derivatives include combinations with deferoxamine, deferiprone, bipyridyl, Desferri-exochelin, picolinic acid, 3-hydroxypicolinic acid, and sodium butyrate as iron/zinc chelators for treating papillomavirus infections
11/11/2004	US20040224991 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/11/2004	US20040224984 Treatment of skin disorders and antiinflammatory agents, fungicides or bactericides
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004	US20040224934 3 -oxo-androstrane carbothioic acid compound
11/11/2004	US20040224931 3-oxo-androstrane carbothioic acid compound
11/11/2004	US20040224923 For therapy of bacterial and/or fungal infections
11/11/2004	US20040224309 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines
11/11/2004	US20040224017 maltodextrin to a drug formulaton containing water insoluble cellulose (especially starch, cellulose ether, xanthan gum or microcrystalline cellulose) to retard the rate of release of the drug to the desired drug release profile when placed in an aqueous system
11/11/2004	US20040223976 Influenza virus vaccine
11/11/2004	US20040223956 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
11/11/2004	CA2558873A1 Treatment of iga1 deposition diseases
11/11/2004	CA2524573A1 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
11/11/2004	CA2524071A1 Toll-like receptor 9 effector agents and uses thereof
11/11/2004	CA2523869A1 Tablets and methods for modified release of hydrophilic and other active agents
11/11/2004	CA2523578A1 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
11/11/2004	CA2523573A1 Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
11/11/2004	CA2523567A1 Method for promoting uninterrupted sleep by administration of trospium chloride
11/11/2004	CA2523561A1 Substituted 1,4-diazepines and uses thereof
11/11/2004	CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004	CA2523413A1 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/11/2004	CA2523266A1 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	CA2522977A1 Immunomodulator phosphonate conjugates
11/11/2004	CA2522833A1 Saposin c-dops: a novel anti-tumor agent
11/11/2004	CA2522711A1 Treating hepatocellular carcinomas using therapeutic viruses
11/11/2004	CA2522431A1 Inhibitors of akt activity
11/11/2004	CA2522430A1 Inhibitors of akt activity
11/11/2004	CA2522262A1 Inhibitors of akt activity
11/11/2004	CA2522043A1 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
11/11/2004	CA2521938A1 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors
11/11/2004	CA2521898A1 Diazabicyclononene derivatives
11/11/2004	CA2520243A1 Pharmaceutical compositions for treating painful neuropathy and methods of treating same
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2004	EP1475086A2 Sibutramine metabolites
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474376A1 Carboxylic acid compounds for use as surfactants
11/10/2004	EP1474133A2 Crystalline solids of carvedilol and processes for their preparation
11/10/2004	EP1474117A1 Composition for inhalation
11/10/2004	EP1240172B1 New aminopropylphosphinic acids
11/10/2004	EP1237562B1 Process for preparing mikania extracts containing mikanolide and dihydromikanolide and use in the treatment of proliferative disorders
11/10/2004	EP1061901B1 Nicotine inhaler
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1544088A Immediate release tablet
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174735C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
11/10/2004	CN1174734C Shampoo compositions
11/10/2004	CN1174731C Cold cream cosmetic composition
11/09/2004	US6814986 Composition for treating obesity and esthetic treatment process
11/09/2004	US6814953 Bronchodilating compositions and methods
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004093830A2 Model for neurodegenerative disorders
11/04/2004	WO2004093829A2 (-)1-(4-sulfamylaryl)-3-substituted-5-heteroaryl-2 pyrazolines as inhibitors of cyclooxygenase-2
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004093825A2 Methods for obtaining colonization factors from bacterial strains
11/04/2004	WO2004093824A2 Peri-operative and peri-procedure nutritional supplementation
11/04/2004	WO2004093823A2 Polyethelene glycol link glp-1 compounds
11/04/2004	WO2004093822A2 Methods for predicting an individual's clinical treatment outcome from sampling a group of patients' biological profiles
11/04/2004	WO2004093821A2 Treatment of anthrax infection using inhibitors of lethal factor protease activity
11/04/2004	WO2004093820A2 Methods and compositions for solid tumor treatment
11/04/2004	WO2004093819A2 Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
11/04/2004	WO2004093818A2 Apparatus and methods for repetitive microjet drug delivery
11/04/2004	WO2004093817A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/04/2004	WO2004093812A2 Compounds that induce neuronal differentiation in embryonic stem cells
11/04/2004	WO2004093810A2 Methods and compositions for treating disorders
11/04/2004	WO2004093809A2 Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
11/04/2004	WO2004093808A2 Novel tumor-associated antigens
11/04/2004	WO2004093807A2 Somatostatin vectors
11/04/2004	WO2004093806A2 Compounds for the treatment of metabolic disorders
11/04/2004	WO2004093805A2 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	WO2004093803A2 Photochemotherapeutic compounds for use in treatment of pin1-associated states
11/04/2004	WO2004093802A2 Prevention of deficits in neurogenesis with anti-inflammatory agents
11/04/2004	WO2004093801A2 Pharmaceutical products
11/04/2004	WO2004093800A2 Thyronamine derivatives and analogs and methods of use thereof
11/04/2004	WO2004093799A2 Thyroid receptor ligands
11/04/2004	WO2004093798A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2004	WO2004093797A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
11/04/2004	WO2004093795A2 Compositions for delivery of drug combinations
11/04/2004	WO2004093793A2 Delivery vehicle for silver ions
11/04/2004	WO2004093790A2 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004	WO2004093788A2 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004	WO2004093787A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
11/04/2004	WO2004093786A2 Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith
11/04/2004	WO2004093785A2 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004	WO2004093784A2 Systems and methods for blood glucose sensing

1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 295